Corvus Pharmaceuticals, Inc. (CRVS)
18.10
-0.10
(-0.55%)
USD |
NASDAQ |
Feb 26, 15:35
Corvus Pharmaceuticals Research and Development Expense (Quarterly) : 8.454M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 1.481B |
| Plus Therapeutics, Inc. | 2.436M |
| Geron Corp. | 15.83M |
| Jaguar Health, Inc. | 3.658M |
| Krystal Biotech, Inc. | 13.23M |